These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9625436)

  • 1. The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein.
    Choi SU; Park SH; Kim KH; Choi EJ; Kim S; Park WK; Zhang YH; Kim HS; Jung NP; Lee CO
    Anticancer Drugs; 1998 Mar; 9(3):255-61. PubMed ID: 9625436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
    Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
    Sun YF; Wink M
    Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
    Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
    Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
    Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
    Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
    Wang PP; Xu DJ; Huang C; Wang WP; Xu WK
    Mol Med Rep; 2014 Jun; 9(6):2131-7. PubMed ID: 24676670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.
    Toffoli G; Simone F; Corona G; Raschack M; Cappelletto B; Gigante M; Boiocchi M
    Biochem Pharmacol; 1995 Oct; 50(8):1245-55. PubMed ID: 7488241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
    Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
    Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
    Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells.
    Lee SY; Rhee YH; Jeong SJ; Lee HJ; Lee HJ; Jung MH; Kim SH; Lee EO; Ahn KS; Ahn KS; Kim SH
    Environ Toxicol; 2011 Aug; 26(4):424-31. PubMed ID: 20196146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel multidrug-resistance modulators, KR-30026 and KR-30031, in cancer cells.
    Choi SU; Lee BH; Kim KH; Choi EJ; Park SH; Shin HS; Yoo SE; Jung NP; Lee CO
    Anticancer Res; 1997; 17(6D):4577-82. PubMed ID: 9494571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids.
    Fu LW; Deng ZA; Pan QC; Fan W
    Anticancer Res; 2001; 21(4A):2273-80. PubMed ID: 11724282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.